Cui Cui
Stock Analyst at Jefferies
(4.43)
# 1,106
Out of 4,339 analysts
32
Total ratings
63.3%
Success rate
32.3%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 0241 Alibaba Health Information Technology Limited | Maintained: Buy | $8.00 → $5.30 | $3.78 | +40.21% | 2 | May 19, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $15.50 | $13.28 | +16.72% | 1 | Apr 3, 2026 | |
| HKG: 9966 Alphamab Oncology | Maintained: Buy | $9.60 | $9.85 | -2.54% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Maintained: Hold | $12.40 | $9.18 | +35.08% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $226.00 | $112.20 | +101.43% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $500.00 | $216.60 | +130.84% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $300.00 → $520.00 | $462.80 | +12.36% | 3 | Aug 19, 2025 | |
| HKG: 6618 JD Health International Inc. | Maintained: Buy | $60.00 → $88.00 | $39.62 | +122.11% | 3 | Aug 15, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Sell | $5.00 | $7.44 | -32.80% | 1 | Jul 30, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $45.00 | $34.38 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 → $60.00 | $57.50 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175.00 → $87.40 | $128.80 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 | $79.85 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.00 | $2.23 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.80 | $8.37 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.00 | $17.43 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110.00 | $31.52 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 → $35.20 | $27.08 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.00 → $25.00 | $34.00 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $18.26 | n/a | 1 | Apr 22, 2020 |
Alibaba Health Information Technology Limited
May 19, 2026
Maintained: Buy
Price Target: $8.00 → $5.30
Current: $3.78
Upside: +40.21%
Genscript Biotech Corporation
Apr 3, 2026
Maintained: Buy
Price Target: $15.50
Current: $13.28
Upside: +16.72%
Alphamab Oncology
Mar 27, 2026
Maintained: Buy
Price Target: $9.60
Current: $9.85
Upside: -2.54%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Maintained: Hold
Price Target: $12.40
Current: $9.18
Upside: +35.08%
Akeso, Inc.
Oct 19, 2025
Maintained: Buy
Price Target: $226.00
Current: $112.20
Upside: +101.43%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Maintained: Buy
Price Target: $500.00
Current: $216.60
Upside: +130.84%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Maintained: Buy
Price Target: $300.00 → $520.00
Current: $462.80
Upside: +12.36%
JD Health International Inc.
Aug 15, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $39.62
Upside: +122.11%
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Maintained: Sell
Price Target: $5.00
Current: $7.44
Upside: -32.80%
WuXi Biologics (Cayman) Inc.
Mar 31, 2025
Maintained: Buy
Price Target: $45.00
Current: $34.38
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $41.00 → $60.00
Current: $57.50
Upside: n/a
Mar 21, 2025
Maintained: Buy
Price Target: $175.00 → $87.40
Current: $128.80
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $40.00
Current: $79.85
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $4.00
Current: $2.23
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $10.80
Current: $8.37
Upside: n/a
Nov 3, 2023
Maintained: Buy
Price Target: $26.00
Current: $17.43
Upside: n/a
Oct 31, 2023
Maintained: Buy
Price Target: $110.00
Current: $31.52
Upside: n/a
Oct 27, 2023
Maintained: Buy
Price Target: $40.00 → $35.20
Current: $27.08
Upside: n/a
Sep 4, 2023
Maintained: Buy
Price Target: $28.00 → $25.00
Current: $34.00
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $18.26
Upside: n/a